Value based pricing not 'feasible' by 2014

a pile of pills

Concerns have been raised that the new “value based pricing” regime for medicines may not be ready in time to replace the existing system.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here